Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
- PMID: 24060861
- DOI: 10.1038/nrc3580
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Erratum in
- Nat Rev Cancer. 2013 Nov;13(11):820
Abstract
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer (NSCLC). The common activation of ALK has led to the use of the ALK tyrosine kinase inhibitor (TKI) crizotinib in a range of patient populations and to the rapid development of second-generation drugs targeting ALK. In this Review, we discuss our current understanding of ALK function in human cancer and the implications for tumour treatment.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases